HQY — HealthEquity Inc. stock price and chart

Share this page

HQY

$92.03-0.52%

as of close, Oct 16, 2026

☾ AH $92.03 -0.52%

HealthEquity Inc.Stock · HealthcareRussell 2000 0.2%Nasdaq Composite 0.02%Russell 3000 0.01%US Stock Market 0.010%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEE

20162019202120242026

30.040.050.060.070.080.090.0100.0110.0010.0M$92.03

2026-10-16

Price$92.03

MA20$93.35

MA50$90.67

Vol4.1M

What would $1,000 invested in HQY be worth today? →

HQY returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $92.03
YTD price return: +0.46%
YTD total return: +0.46%
Next earnings: Dec 2, 2026
Market cap: 7.6B2016-12 2.4B2026-10 7.6B+216.6% over the window
Enterprise value: 8.3B
Shares outstanding: 82.7M2016-07 58.6M2026-07 82.7M+41.1% over the window
52W low: $72.76
52W high: $107.62
From 52W high: -14.49%
From 52W low: +26.48%
52W range: 55%

Volume

Rel volume: 0.64×
30D volume: 855.6K
30D $ vol: 78.6M

Fundamentals

Sales (ttm): 1.4B2016-07 154.6M2026-07 1.4B+780.8% over the window
Sales/share: $16.472016-07 $2.642026-07 $16.47+524.5% over the window
EPS (ttm): $2.762016-07 $0.402026-07 $2.76+590.5% over the window
FCF (ttm): 487.7M2016-07 32.4M2026-07 487.7M+1404.5% over the window
FCF/share: $5.902016-07 $0.552026-07 $5.90+966.6% over the window
Book value/share: $24.062016-07 $4.082026-07 $24.06+489.2% over the window
Net margin: 17.36%2016-07 15.2%2026-07 17.4%+14.1% over the window
ROE: 11.88%2016-07 9.8%2026-07 11.9%+21.0% over the window
ROA: 7.23%2016-07 9.4%2026-07 7.2%-23.0% over the window
Debt / equity: 0.47×2019-01 0.002026-07 0.47
Current ratio: 2.992016-07 19.442026-07 2.99-84.6% over the window

Growth (CAGR, ttm) · 10Y

Sales: +7.35%2025-07-31 → 2026-07-311.3B → 1.4B (+7.3% total)+13.24%2023-07-31 → 2026-07-31937.9M → 1.4B (+45.2% total)+12.96%2021-07-31 → 2026-07-31740.8M → 1.4B (+83.9% total)+24.31%2016-07-31 → 2026-07-31154.6M → 1.4B (+780.8% total)
Net income: +62.22%2025-07-31 → 2026-07-31145.8M → 236.5M (+62.2% total)+164.13%2023-07-31 → 2026-07-3112.8M → 236.5M (+1744.0% total)+218.42%2021-07-31 → 2026-07-31723K → 236.5M (+32610.1% total)+25.97%2016-07-31 → 2026-07-3123.5M → 236.5M (+905.5% total)
FCF: +33.50%2025-07-31 → 2026-07-31365.4M → 487.7M (+33.5% total)+32.32%2023-07-31 → 2026-07-31210.5M → 487.7M (+131.7% total)+23.37%2021-07-31 → 2026-07-31170.7M → 487.7M (+185.8% total)+31.15%2016-07-31 → 2026-07-3132.4M → 487.7M (+1404.5% total)
Shares: -4.00%2025-07-31 → 2026-07-3186.2M → 82.7M (-4.0% total)-1.15%2023-07-31 → 2026-07-3185.6M → 82.7M (-3.4% total)-0.19%2021-07-31 → 2026-07-3183.5M → 82.7M (-1.0% total)+3.50%2016-07-31 → 2026-07-3158.6M → 82.7M (+41.1% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +67.68%2025-07-31 → 2026-07-31$1.65 → $2.76 (+67.6% total)+163.94%2023-07-31 → 2026-07-31$0.15 → $2.76 (+1740.0% total)+214.48%2021-07-31 → 2026-07-31$0.01 → $2.76 (+30633.9% total)+21.32%2016-07-31 → 2026-07-31$0.40 → $2.76 (+590.5% total)
Sales/share: +11.82%2025-07-31 → 2026-07-31$14.73 → $16.47 (+11.8% total)+14.56%2023-07-31 → 2026-07-31$10.95 → $16.47 (+50.3% total)+13.17%2021-07-31 → 2026-07-31$8.87 → $16.47 (+85.6% total)+20.11%2016-07-31 → 2026-07-31$2.64 → $16.47 (+524.5% total)
FCF/share: +39.05%2025-07-31 → 2026-07-31$4.24 → $5.90 (+39.0% total)+33.85%2023-07-31 → 2026-07-31$2.46 → $5.90 (+139.9% total)+23.61%2021-07-31 → 2026-07-31$2.04 → $5.90 (+188.5% total)+26.71%2016-07-31 → 2026-07-31$0.55 → $5.90 (+966.6% total)
Book value/share: -3.43%2025-07-31 → 2026-07-31$24.91 → $24.06 (-3.4% total)+1.86%2023-07-31 → 2026-07-31$22.77 → $24.06 (+5.7% total)+1.53%2021-07-31 → 2026-07-31$22.30 → $24.06 (+7.9% total)+19.41%2016-07-31 → 2026-07-31$4.08 → $24.06 (+489.2% total)
Price: +1.09%2025-10-16 → 2026-10-16$91.04 → $92.03 (+1.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+7.07%2023-10-16 → 2026-10-16$74.98 → $92.03 (+22.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+7.82%2021-10-15 → 2026-10-16$63.15 → $92.03 (+45.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+9.65%2016-10-14 → 2026-10-16$36.61 → $92.03 (+151.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +1.09%2025-10-16 → 2026-10-16$91.04 → $92.03 (+1.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+7.07%2023-10-16 → 2026-10-16$74.98 → $92.03 (+22.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+7.82%2021-10-15 → 2026-10-16$63.15 → $92.03 (+45.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+9.65%2016-10-14 → 2026-10-16$36.61 → $92.03 (+151.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 33.3×2016-12 94.552026-10 32.21-65.9% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 21.7×2016-12 61.072026-10 21.68-64.5% over the window
Fwd P/E: 16.9×
P/S (ttm)Market cap ÷ TTM revenue.: 5.6×2016-12 14.372026-10 5.59-61.1% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 3.8×2016-12 9.522026-10 3.83-59.8% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 15.6×2016-12 67.572026-10 15.62-76.9% over the window
EV/EBITDA (fy): 16.4×
EV/Sales (ttm): 6.1×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 6.41%2016-10 1.5%2026-07 6.5%+336.5% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-07-31) ÷ shares_at(2025-07-31) = 1 − 82.7M ÷ 86.2M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 4.00%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (4.00%) + dividends paid over that year ($0) ÷ market_cap_at(2025-07-31) ($8.4B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 4.00%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($404.5M) ÷ today's market cap ($7.6B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 5.31%2016-10 1.0%2026-07 5.4%+448.6% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $404.5M + TTM dividends $0) ÷ today's market cap ($7.6B). Same caveat as the cash buyback yield.: 5.31%2016-10 1.0%2026-07 5.4%+448.6% over the window

Vs own 10Y history

P/E: 5th
P/OI: 4th
P/S: 9th
P/B: 51st
P/FCF: 4th

Bar = where today’s multiple sits in HQY’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-0.52%

-0.63%

-4.14%

-6.75%

YTD

+0.46%

+1.09%

+45.73%

Financial statements

Open full HQY financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

HQY — HealthEquity Inc. price, chart and key statistics